��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
友輝(4933)
月營收
季盈餘
2025/03/01
79.00元 (友輝股價)
2025/03/01
28.17% (年增率)
282百萬元 (營收)
友輝(4933) 年度營收走勢圖
友輝(4933)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
282,072
17.60%
220,085
28.17%
744,941
21.87%
114/02
239,864
7.56%
155,451
54.30%
462,869
18.33%
114/01
223,005
-28.03%
235,702
-5.39%
223,005
-5.39%
113/12
309,861
6.96%
238,642
29.84%
2,949,524
17.42%
113/11
289,697
2.16%
231,998
24.87%
2,639,663
16.12%
113/10
283,558
18.80%
236,575
19.86%
2,349,966
15.13%
113/09
238,691
-10.05%
238,710
-0.01%
2,066,408
14.51%
113/08
265,347
16.21%
257,183
3.17%
1,827,717
16.72%
113/07
228,336
-10.37%
207,806
9.88%
1,562,370
19.38%
113/06
254,757
9.00%
222,655
14.42%
1,334,034
21.17%
113/05
233,728
-0.25%
238,336
-1.93%
1,079,277
22.88%
113/04
234,311
6.46%
197,184
18.83%
845,549
32.13%
113/03
220,085
41.58%
188,474
16.77%
611,238
38.05%
113/02
155,451
-34.05%
145,955
6.51%
391,153
53.82%
113/01
235,702
-1.23%
108,337
117.56%
235,702
117.56%
112/12
238,642
2.86%
173,376
37.64%
2,511,855
9.58%
112/11
231,998
-1.93%
171,514
35.26%
2,273,213
7.28%
112/10
236,575
-0.89%
148,836
58.95%
2,041,215
4.82%
112/09
238,710
-7.18%
123,544
93.22%
1,804,640
0.34%
112/08
257,183
23.76%
144,434
78.06%
1,565,930
-6.51%
112/07
207,806
-6.67%
173,826
19.55%
1,308,747
-14.49%
112/06
222,655
-6.58%
191,420
16.32%
1,100,941
-18.85%
112/05
238,336
20.87%
211,246
12.82%
878,286
-24.63%
112/04
197,184
4.62%
261,854
-24.70%
639,950
-32.92%
112/03
188,474
29.13%
273,821
-31.17%
442,766
-36.03%
112/02
145,955
34.72%
196,905
-25.88%
254,292
-39.22%
112/01
108,337
-37.51%
221,474
-51.08%
108,337
-51.08%
111/12
173,376
1.09%
292,679
-40.76%
2,292,250
-22.62%
111/11
171,514
15.24%
250,439
-31.51%
2,118,874
-20.63%
111/10
148,836
20.47%
209,289
-28.88%
1,947,360
-19.50%
111/09
123,544
-14.46%
262,615
-52.96%
1,798,524
-18.61%
111/08
144,434
-16.91%
254,354
-43.22%
1,674,980
-13.98%
111/07
173,826
-9.19%
254,549
-31.71%
1,530,546
-9.59%
111/06
191,420
-9.39%
228,046
-16.06%
1,356,720
-5.67%
111/05
211,246
-19.33%
254,783
-17.09%
1,165,300
-3.72%
111/04
261,854
-4.37%
262,548
-0.26%
954,054
-0.15%
111/03
273,821
39.06%
243,427
12.49%
692,200
-0.11%
111/02
196,905
-11.09%
418,379
111/01
221,474
-24.33%
221,474
110/12
292,679
16.87%
2,962,247
110/11
250,439
19.66%
2,669,568
110/10
209,289
-20.31%
2,419,129
110/09
262,615
3.25%
2,209,840
110/08
254,354
-0.08%
1,947,225
110/07
254,549
11.62%
1,692,871
110/06
228,046
-10.49%
1,438,322
110/05
254,783
-2.96%
1,210,276
110/04
262,548
7.85%
955,493
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
